InvestorsHub Logo

mrwrn2010

02/18/19 11:17 PM

#309932 RE: meshcan #309930

I believe you’re referring to the process of getting Isradipine “on label” for Parkinson’s. MD’s can prescribe it to their PD patients off-label if they so choose while the drug makes its way through the normal approval process (assuming positive results from this study).

https://www.fda.gov/forpatients/other/offlabel/default.htm